caffeic acid phenethyl ester has been researched along with Mediastinitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aytacoglu, BN; Bayindir, I; Coskun, B; Dikmengil, M; Ersoz, G; Kose, N; Oguz, I; Ozeren, M; Sucu, N; Tamer, L | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and Mediastinitis
| Article | Year |
|---|---|
Combined therapy of teicoplanin and caffeic acid phenethyl ester (CAPE) in the treatment of experimental mediastinitis in the rat.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Caffeic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Mediastinitis; Methicillin Resistance; Osteomyelitis; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin | 2006 |